1-5 of 5
Authors: Maria Vincenza Mastrolia
Sort by
Journal Article
Comment on: Achieving inactive disease in enthesitis-related arthritis with secukinumab following TNF-inhibitor failure
Valerio Maniscalco and others
Rheumatology, Volume 63, Issue 11, November 2024, Pages e319–e320, https://doi.org/10.1093/rheumatology/keae148
Published: 09 March 2024
Journal Article
Early anakinra treatment improves cardiac outcome of multisystem inflammatory syndrome in children, regardless of disease severity
Andrea Taddio and others
Rheumatology, Volume 63, Issue 2, February 2024, Pages 366–375, https://doi.org/10.1093/rheumatology/kead381
Published: 30 August 2023
Journal Article
Behçet syndrome in children and adults: discovering similarities and differences by a comparative study
Maria Vincenza Mastrolia and others
Rheumatology, Volume 62, Issue SI2, February 2023, Pages SI189–SI195, https://doi.org/10.1093/rheumatology/keac347
Published: 15 June 2022
Journal Article
Canakinumab in systemic juvenile idiopathic arthritis: real-world data from a retrospective Italian cohort
Arianna De Matteis and others
Rheumatology, Volume 61, Issue 4, April 2022, Pages 1621–1629, https://doi.org/10.1093/rheumatology/keab619
Published: 03 August 2021
Journal Article
OBSIDIAN – real-world evidence of originator to biosimilar drug switch in juvenile idiopathic arthritis
Ilaria Maccora and others
Rheumatology, Volume 61, Issue 4, April 2022, Pages 1518–1528, https://doi.org/10.1093/rheumatology/keab572
Published: 17 July 2021
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals